For the rest of the genes (PABPC1, KRT5, MALAT1, RGS5, SPP1, S100A9, ADAM6, CHGA, SCG2, PDLIM5, SILV), they were neither significantly enriched in the pathway nor found to be tumor-related in GeneCard. This evidence concerns the gene PMEL and neoplasm.